RPTX – repare therapeutics inc. - common shares (US:NASDAQ)
Stock Stats
News
Repare Therapeutics Announces Leadership Transitions
Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Repare Therapeutics Inc. (NASDAQ: RPTX) had its price target lowered by analysts at HC Wainwright from $10.00 to $5.00. They now have a "buy" rating on the stock.
Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Form 4 Repare Therapeutics Inc. For: Apr 02 Filed by: Forte Steve
Form 8-K Repare Therapeutics Inc. For: Mar 31
Form 4 Repare Therapeutics Inc. For: Mar 12 Filed by: Forte Steve
Form 4 Repare Therapeutics Inc. For: Mar 12 Filed by: Zinda Michael
Form 4 Repare Therapeutics Inc. For: Mar 12 Filed by: Segal Lloyd Mitchell
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.